Cargando…
Applying lessons from the Ebola vaccine experience for SARS-CoV-2 and other epidemic pathogens
The world is experiencing an unprecedented global pandemic of coronavirus disease 2019 (COVID-19) caused by a novel coronavirus, Severe Acute Respiratory Syndrome-coronavirus-2 (SARS-CoV-2). Development of new vaccines and therapeutics are important to achieve long-term prevention and control of the...
Autores principales: | Wolf, Jayanthi, Bruno, Samantha, Eichberg, Michael, Jannat, Risat, Rudo, Sharon, VanRheenen, Susan, Coller, Beth-Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295741/ https://www.ncbi.nlm.nih.gov/pubmed/32566261 http://dx.doi.org/10.1038/s41541-020-0204-7 |
Ejemplares similares
-
Development of Pandemic Vaccines: ERVEBO Case Study
por: Wolf, Jayanthi, et al.
Publicado: (2021) -
Ebola: epidemic echoes and the chronicle of a tragedy foretold
por: Honigsbaum, Mark
Publicado: (2014) -
The Ebola epidemic is ongoing in West Africa and responses from China are positive
por: Zhao, Jing-Min, et al.
Publicado: (2015) -
Ebola in West Africa—CDC’s Role in Epidemic Detection, Control, and Prevention
por: Frieden, Thomas R., et al.
Publicado: (2015) -
Rethinking the Discharge Policy for Ebola Convalescents in an Accelerating Epidemic
por: O'Dempsey, Tim, et al.
Publicado: (2015)